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Background: The aim of this study was to assess the ability of commercially available single frequency bioelectrical impedance analysis
(BIA) to predict total body water and hence body composition in a cohort of children with cystic fibrosis (CF).
Methods: In 56 (31 girls, 25 boys) children aged 4 to 18 years, total body water was predicted using BIA and measured using a deuterium
oxide dilution technique. Each child provided a urine sample before consuming 0.5 g/kg body weight 10% deuterium oxide. A further urine
sample was collected between 4 and 6 h later.
Results: There was a mean bias between predicted and measured total body water of 1.1 L. The bias was consistent across the range of total
body water measured in this study.
The relationship between height2/impedance and measured total body water was TBW=0.35+0.74*height2/impedance. This equation is
similar to other equations found in healthy children.
Conclusion: We have shown that a commercially available bioelectrical device underestimates measured total body water. We have generated
a prediction equation for the population studied, which we believe might enhance the accuracy of the method in children with cystic fibrosis.
D 2004 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
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Cystic fibrosis (CF) is one of the most common
autosomal recessive genetic diseases amongst Caucasians
[1]. The clinical features include meconium ileus, failure to
thrive due to pancreatic insufficiency and acute and chronic
respiratory inflammation leading to bronchiectasis. Nutri-
tional therapy is one of the key elements in the treatment of
cystic fibrosis not least because of the well-documented
association between malnutrition and survival [2].
Over the past few decades, more aggressive and
improved nutritional therapy has resulted in improvements1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2004.06.007
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E-mail address: ps.davies@uq.edu.au (P.S.W. Davies).in the growth and lung health of children with CF, which in
turn has led to increased survival. In assessing growth and
nutritional status, measurements such as height and weight
are useful, but the latter tells us nothing about the
components of body weight that may be important in cystic
fibrosis namely, the amount of fat-free mass and fat mass,
i.e., body composition.
There are many ways in which body composition can be
assessed, and, ideally, a method should be accurate, precise,
acceptable to the child, economical, and readily available.
Whilst methods such as Dual X-ray absorptiometry
(DXA), for example, might provide accurate and precise
data, it is an expensive method and only available at
specialised centres. Other methods such as underwater
weighing, for example, again may yield accurate and
precise data, but will not be acceptable to many children,3 (2004) 243–247ed by Elsevier B.V. All rights reserved.
Table 1
Some basic physical characteristics of the children studied
Mean S.D. Range
Age (years) 10.29 3.63 4.25–17.68
Height (cm) 136.5 19.4 102.4–175.5
Weight (kg) 33.5 12.9 15.4–62.3
Impedance (V) 737 95 483–951
Measured total body water (L) 20.1 8.0 10.2–42.7
Predicted total body water (L) 19.0 7.5 9.2–38.2
Bias (L) 1.1 2.1 3.7–9.3
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tions may be violated in disease states.
Bioelectrical impedance analysis (BIA), on the other
hand, is extremely precise, acceptable and relatively
affordable, and consequently is widely used. The basis of
the method is that the bioelectrical impedance of the
human body is related to the volume of total body water.
Once total body water is known, fat-free mass can be
calculated. The electrical theory of the method is given in
the Appendix.
In order, therefore, to predict total body water from
simple measurements of height and bioelectrical impedance,
regression equations must be developed by actually
measuring total body water in the first instance.
One relatively straightforward way of measuring TBW is
by using a stable isotope of hydrogen, deuterium, in the form
of water (2H2O). This method is based upon dilution
principles, with the subject consuming a known volume of
2H2O usually relative to body weight, of known concen-
tration or enrichment. Following a period of equilibrium of
between 4 and 6 h, a sample of body water, i.e., urine, saliva,
or plasma, is taken and the enrichment of isotope in that
sample measured. These data then lead to the calculation of
the dilution volume and hence total body water.
To the best of our knowledge, the relationship between
total body water and H2/I has been investigated on only two
occasions in individuals with cystic fibrosis and never in a
cohort of just children.
The first of these studies [3] measured total body water
and BIA in a group of 20 males with cystic fibrosis ranging
in age from 7 to 39 years. At the same time, similar
measurements were undertaken in a cohort of controls
without CF of similar age range. The key finding of this
study was that the slopes of the regression equations relating
total body water to height2/impedance were significantly
different between the patients and the controls. The
conclusion drawn was that there was a need to develop
specific prediction equations for patients with cystic
fibrosis.
The second study [4] carried out a similar approach in
10 adults with CF and 10 controls. The authors state that,
whilst height2/impedance correlated well with the measure-
ments of total body water in patients with cystic fibrosis
and controls (correlation coefficient r=0.88 and r=0.87,
respectively), the regression equations developed from the
data were not the same. Indeed, there is a marked
difference between the intercepts being equivalent to 1.2
L of water in the controls but 11.1 L of water in the
patients with cystic fibrosis.
Before the method can be used with confidence in
children with CF, it is important to consider whether the
prediction equation developed from healthy children and
installed in commercially available bioelectrical impedance
apparatus can successfully predict total body water in this
clinical condition and if not, to attempt to derive an
acceptable regression equation for this population.2. Materials and methods
A total of 56 children (31 girls, 25 boys) with CF were
recruited from weekly outpatient’s clinics (n=42) or were
inpatients (n=14) at the Royal Children’s Hospital, Bris-
bane. The subjects were a convenience sample and
consisted of children with a range of infection status.
Diagnosis of cystic fibrosis was confirmed in all cases by
a sweat test. Verbal informed consent was obtained from the
child and written informed consent obtained from the
parents. The study was approved by the University of
Queensland Ethical Committee and Royal Children’s
Hospital Ethical Committee.
2.1. Anthropometry
Measurements of the patient’s height were made using a
stadiometer (Raven Equipment, England) and were recorded
to the nearest 0.1 cm. Weight was measured with the subject
wearing light clothing using a recently calibrated digital
scale and recorded to 0.1 kg.
2.2. Total body water
Total body water was measured using a stable isotope of
hydrogen, deuterium, in the form of water, i.e., deuterium
oxide (2H2O).
A baseline urine sample was obtained to determine the
natural background enrichment of 2H. An oral dose of a
10% 2H2O solution (0.5 g/kg body weight) was then
administered. Between 4 and 6 h post dose, another urine
sample was collected. During this time, the children were
allowed to eat and drink normally. TBW was determined by
analysing the predose and postdose urine sample, a tap
water sample, and a sample of the dose given to the patient
using isotope ratio mass spectrometry (Hydra, PDZ Europa,
Crewe, UK). Samples were measured in duplicate and
expressed as delta units relative to standard mean ocean
water (SMOW). The equation used for the calculation of
deuterium dilution space (Nd) was as follows: [5]
N ¼ TA=að ÞT Ea Etð Þ= Es Epð Þð Þ
where A is the amount of isotope given in grams, a is the
portion of the dose in grams retained for mass spectrometer
analysis, T is the amount of tap water in which the portion
Fig. 1. Bland-Altman plot of the mean of predicted and measured total body water and their difference.
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the isotopic enrichments in delta units relative to SMOW of
the portion of the dose, the tap water used, the predose urine
sample, and the postdose urine sample, respectively. The
deuterium dilution space was converted to TBW using the
formula of Schoeller et al. [6].
2.3. BIA
Impedance, and hence predicted TBW, was measured
using a Bodystat-1500 analyser (Bodystat, UK). This BIA
equipment requires that the operator enter the patient’s
gender, age, height, weight, and activity level. After theFig. 2. The relationship between height2/impinput of this information, the BIA machine introduced a
800-AA current at 50 KHz into the subject’s body and
measured the voltage drop while patients were in a supine
position with the arms and legs abducted from the midline to
avoid limb contact. The BIA was performed using a
tetrapolar technique. The children had surface electrodes
placed on their hands and feet: two on the foot at the
proximal base of the metatarsal phalanges and ventrally
between the malleolus lateralis and medialis; and two on the
hand at the proximal base of the metacarpal phalanges on
the wrist dorsum and between the distal ends of the ulna and
radius. All measurements were performed on the patient’s
right side.edance and measured total body water.
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Some basic physical characteristics of the patients are
shown in Table 1. A Bland–Altman plot [7] of the mean of
the predicted and measured total body water and the
difference between predicted and measured total body water
is shown in Fig. 1. The bias between the two methods was
1.1 L or about 6% of the mean total body water. This bias is
significantly different from a mean bias of zero which would
indicate good agreement. The 95% confidence interval of
the bias was F2.1 L of water, i.e., from 3.1 L to +5.3 L.
There was a nonsignificant correlation of 0.22 between the
mean and the differences indicating that there was no
significant change in the bias over the range of measure-
ments taken in this particular study. The relationship
between height2/impedance and measured total body water
is shown in Fig. 2, along with the regression equation
relating the two variables.4. Discussion
This study aimed to assess the ability of commercially
available bioelectrical impedance apparatus to predict total
body water in a cohort of children with cystic fibrosis.
A Bland–Altman analysis revealed that, at the population
level, the mean bias between the predicted and measured
total body water was 1.1 L; that is, the bioelectrical
impedance apparatus underestimated measured total body
water by about 6% on average.
Nevertheless, the 95% confidence interval of the bias
was large, being 2.1 L. This indicates that predicted total
body water may be up to 3.1 L below or 5.3 L above the
measured total body water, which, we would suggest, is
unacceptable for clinical purposes when attempting to
evaluate an individual. A measurement of 2.1 L of body
water is approximately equivalent to 2.8 kg of fat-free
mass. There was a nonsignificant correlation (r=0.22)
between the mean of measured and predicted total body
water and their differences, indicating that the mean bias of
1.1 L was consistent across the range of body water
measured in this study. However, visual inspection would
suggest that the variation in differences between measured
and predicted total body water is greater at larger body
water measures. This can be appreciated more fully if one
considers that the range of differences between measured
and predicted total body water of those measurements that
are below 20 L (n=35) is 1.1 L to 4.3 L, while the
equivalent values for body water measurements above 20
L is 3.7 L to 9.3 L. This would suggest that error is
likely to be greater in individuals who have a greater
volume of body water, which is also a proxy of body
weight and/or age.
The regression equation that relates height2/impedance to
measured total body water has an intercept of 0.35 and a
slope of 0.74. These values are very similar to those foundin studies that relate height2/impedance to total body water
in normal healthy children [8–11], although the slope is
slightly greater in the children studied here.
A comparison with the two previous studies that have
assessed bioelectrical impedance and total body water in
adults and mixed adult and children cohorts is not
straightforward.
In the study of Azcue et al. [3], the regression equation
that relates height2/impedance to total body water in the
subjects with cystic fibrosis is similar to that found here,
being TBW=2.39+0.68 H2/I. The conclusion reached by
those authors that the equations found in the patients with
cystic fibrosis and those found in the normal controls are
markedly different is in fact due to the regression equation
found in the controls being significantly different from any
other published equations for normal controls found in the
literature. The equation has an extremely high intercept
being approximately 6.6 L whilst the slope is 0.54, which is
closer to expected values.
In the study of Borowitz and Conboy [4], it is the adults
with cystic fibrosis that have an unusual regression
equation, with, again, an extremely high intercept being
11.1 L and a low slope being 0.48.
Bioelectrical impedance is a very simple, rapid, non-
invasive, and acceptable method of predicting body
composition in children. These features also make it
appealing for the use in sick children. In this study, we
have shown that a commercially available bioelectrical
impedance device underestimates measured total body
water by an amount that would not be acceptable at the
individual level. Nevertheless, we have generated a
prediction equation for the population, which we believe,
might enhance the accuracy of the method in children with
cystic fibrosis.
A cross-validation study would add weight to the validity
of the equation, but we currently believe that the equation
produced within this study can be used in children with
cystic fibrosis with confidence.Acknowledgment
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IlP(L/P) where P is the resistivity index of the
conductor and A is its cross sectional area.
If we multiply the above equation by L, we get
IlP
LL
AL
IdP
L2
V
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Rearrangement gives us
VlP
L2
I
In humans, L is usually taken as being height or stature as so
TBWlP
L2
I
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